Franchise Group is a holding company. Through its subsidiaries, the company is engaged as a franchisor and operator of a system of income tax preparation offices located in the United States and Canada. The company also facilitates refund-based tax settlement financial products, such as Refund Transfer products and personal income tax refund discounting. The company also provides online tax preparation services. The company's tax settlement products: refund transfer products, which involves direct deposit of the customer's tax refund into a newly established temporary bank account in the customer's name and refund-based loans, which provides digital online tax services.

Hersha Hospitality Trust is a real estate investment trust. The company invests primarily in institutional grade hotels in primary urban gateway markets including New York, Washington, District of Columbia, Boston, Philadelphia, South Florida and select markets on the West Coast. The company owns its hotels and its investments in joint ventures through its operating partnership, Hersha Hospitality Limited Partnership, for which the company serves as the sole general partner. The majority of the company's wholly-owned hotels are managed by Hersha Hospitality Management, L.P., a management company owned by certain of its trustees and executive officers and other unaffiliated third party investors.

Idera Pharmaceuticals is a biopharmaceutical company focused on the clinical development and commercialization of drug candidates for both oncology and rare disease indications. The company's focus is on its Toll-like receptor (TLR), agonist, tilsotolimod (IMO-2125), for oncology. The company is developing tilsotolimod, via intratumoral injection, for the treatment of anti-PD1 refractory metastatic melanoma in combination with ipilimumab, an anti-CTLA4 antibody marketed as Yervoy? by Bristol-Myers Squibb Company (BMS). The company is also evaluating intratumoral tilsotolimod in combination with nivolumab, an anti-PD1 antibody marketed as Opdivo? by BMS, and ipilimumab for the treatment of multiple solid tumors.

Mersana Therapeutics is a clinical stage biopharmaceutical company focused on developing antibody drug conjugates (ADCs) for cancer patients. The company's primary product candidate, XMT-1536, is an ADC targeting NaPi2b, an antigen broadly expressed in ovarian cancer and non small cell lung cancer. In addition, the company has established research and development partnerships with Merck KGaA and Asana Biosciences for the development and commercialization of additional ADC product candidates against a limited number of targets selected by the company's partners based on its Dolaflexin platform.

NGM Biopharmaceuticals is a biopharmaceutical company. The company is focused on the following programs: Aldafermin, which is for the treatment of non-alcoholic steatohepatitis (NASH); NGM313 (MK-3655), which is for the treatment of NASH and type 2 diabetes; NGM120, which is designed to block the effects of elevated growth differentiation factor 15 levels on cancer anorexia/cachexia syndrome, and, possibly, tumors; NGM217, which is designed to restore pancreatic islet function and increase insulin production in patients with diabetes; NGM621, which is designed to decrease levels of this protein implicated in the dry form of AMD; and NGM395, which is for the treatment of metabolic syndrome.

Salem Media Group is a domestic multimedia company focusing on Christian and conservative content, with media properties comprising radio broadcasting, digital media, and publishing. The company's operating segments are: Broadcasting, which includes the operating results of its radio stations, broadcast networks, and its national sales agencies including its new digital agency Salem Surround; Digital Media, which provides Christian, conservative, investing and health-themed content, e-commerce, audio and video streaming, and other resources digitally through the web; and Publishing, which include Regnery Publishing, Salem Author Services; and Singing News? magazine.

Simply Good Foods is a developer, marketer and seller of nutritional foods and snacking products. The company's product portfolio consists primarily of nutrition bars, ready-to-drink shakes, snacks and confectionery products marketed under the Atkins?, SimplyProtein?, and Atkins Endulge? brand names. The Atkins brand approach focuses on a healthy eating approach with reduced levels of refined carbohydrates and sugars and encourages the consumption of lean protein, fiber, fruits, vegetables and healthy fats. Through third-party partnerships, the company provides complementary Atkins branded frozen meals.

SunPower is a holding company. Through its subsidiaries, the company is an energy company that delivers solar solutions to residential, commercial, and power plant customers worldwide. The company has two segments: SunPower Energy Services, which refers to sales of solar energy solutions in the North America including direct sales of turn-key engineering, procurement and construction services, and sales to resellers, among other; and SunPower Technologies, which refers to its technology development, worldwide solar panel manufacturing operations, equipment supply to resellers, commercial and residential end-customers outside of North America, and worldwide power plant project development and project sales.